|
Monday, March 24 — 1:00 PM — Maryland Suite
Click on the numbers in parentheses to display abstracts.
Section H - LIVER & PANCREAS PATHOLOGY
Chaired by: Michael Torbenson and Elizabeth Brunt
| 1:00 |
Identification of Novel Tumor Markers in Biliary Carcinomas Using Tissue Microarrays
(1304)
SL Swierczynski, A Maitra, SC Abraham, CA Iacobuzio-Donahue, R Ashfaq, RD Schulick, A Rahman, CJ Yeo, RH Hruban, P Argani
Johns Hopkins University School of Medicine, Baltimore, MD; University of Texas Southwestern Medical Center, Dallas, TX
|
| 1:15 |
Survivin Expression in Hepatocellular Carcinoma: Correlation with Proliferation and Prognosis
(1243)
AC Fields, G Cotsonis, D Sexton, C Cohen
Emory University School of Medicine, Atlanta, GA; Emory University, Atlanta, GA
|
| 1:30 |
Epidermal Growth Factor Receptor Is over Expressed in 27% of Hepatocellular Carcinomas, but Is Not Associated with ERK1/2 or STAT-3 Activation
(1299)
F Sahin, R Ashfaq, J Boitnott, GH Su, M Torbenson
Johns Hopkins Hospital, Baltimore, MD; University of Texas Southwestern, Dallas, TX
|
| 1:45 |
Aberrant Promoter Methylation Profile of Tumor Suppressor Genes in Hepatocellular Carcinoma
(1314)
B Yang, M Guo, JG Herman, DP Clark
Johns Hopkins Medical Institutions, Baltimore, MD
|
| 2:00 |
Influence of Age on Hepatocellular Carcinoma
(1282)
M Mino, H Varnholt, A Muzikansky, B Terris, KP Batts, H Yamabe, JF Flejou, K Cleary, JN Vauthey, GY Lauwers
Massachusetts General Hospital, Boston, MA; Hopital Beaujon, Paris, France; Mayo Clinic, Rochester, MN; Kyoto University Hospital, Kyoto, Japan; MD Anderson Cancer Center, Houston, TX
|
| 2:15 |
Histologic Changes Mimicking Biliary Disease in Liver Biopsy with Venous Outflow Obstruction
(1266)
S Kakar, LJ Burgart
UCSF and VA Medical Center, San Francisco, CA; Mayo Clinic, Rochester, MN
|
| 2:30 |
Antibody Mediated Rejection of Liver Allografts: Utility of C4d Immunostains in Diagnosis
(1235)
R Anders, M Tretiakova, C Gong, J Hart
University of Chicago Hospitals, Chicago, IL
|
| 2:45 |
Leptin as a Marker of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
(1292)
LM Petrovic, LM Alba, KD Lindor, JA Talwakar, P Angulo
Weill Medical College Cornell University, New York, NY; Mayo Clinic, Rochester, MN
|
| 3:00 |
RECESS, EXHIBITS, POSTER SESSION II
|
| 4:30 |
NATHAN KAUFMAN TIMELY TOPICS LECTURE
Dr. Irving L. Weissman
Stem Cell Biology: Past, Present and Future
Marriott Ballroom
|
|
|
